{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:31:43Z","timestamp":1793496703021,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is becoming a major contributor to cardiovascular disease. One of the early signs of T2DM associated cardiovascular events is the development of vascular dysfunction. This dysfunction has been implicated in increasing the morbidity and mortality of T2DM patients. One of the important characteristics of vascular dysfunction is the impaired ability of endothelial cells to produce nitric oxide (NO). Additionally, decreases in the availability of NO is also a major contributor of this pathology. NO is produced by the activity of endothelial NO synthase (eNOS) on its substrate, L-arginine. Reduced availability of <jats:sc>L<\/jats:sc>-arginine to eNOS has been implicated in vascular dysfunction in diabetes. Arginase, which metabolizes <jats:sc>L<\/jats:sc>-arginine to urea and ornithine, competes directly with NOS for L-arginine. Hence, increases in arginase activity can decrease arginine levels, reducing its availability to eNOS and decreasing NO production. Diabetes has been linked to elevated arginase and associated vascular endothelial dysfunction. We aimed to determine levels of plasma NO and arginase activity in (T2DM) patients and the effects of L-citrulline supplementation, a natural arginase inhibitor, on inhibiting arginase activity in these patients. Levels of arginase correlated with HbA1c levels in diabetic patients. Twenty-five patients received <jats:sc>L<\/jats:sc>-citrulline supplements (2000\u00a0mg\/day) for 1 month. Arginase activity decreased by 21% in T2DM patients after taking <jats:sc>L<\/jats:sc>-citrulline supplements. Additionally, plasma NO levels increased by 38%. There was a modest improvement on H1Ac levels in these patients, though not statistically significant. The effect of <jats:sc>L<\/jats:sc>-citrulline on arginase activity was also studied in bovine aortic endothelial cells (BAECs) grown in high glucose (HG) conditions. HG (25\u00a0mM, 72\u00a0h) caused a 2-fold increase in arginase activity in BAECs and decreased NO production by 30%. <jats:sc>L<\/jats:sc>-citrulline (2.5\u00a0mM) completely prevented the increase in arginase activity and restored NO production levels. These data indicate that <jats:sc>L<\/jats:sc>-citrulline can have therapeutic benefits in diabetic patients through increasing NO levels and thus maintaining vascular function possibly through an arginase inhibition related pathway.<\/jats:p>","DOI":"10.3389\/fphar.2020.584669","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T08:53:29Z","timestamp":1608627209000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["L-Citrulline Supplementation Increases Plasma Nitric Oxide Levels and Reduces Arginase Activity in Patients With Type 2 Diabetes"],"prefix":"10.3389","volume":"11","author":[{"given":"Alia","family":"Shatanawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther S.","family":"Momani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruaa","family":"Al-Aqtash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir N.","family":"Gharaibeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1042\/0264-6021:3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem. J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/cvr\/cvq081","article-title":"Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension","volume":"87","author":"Bagnost","year":"2010","journal-title":"Cardiovasc. Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1161\/01.CIR.0000092948.04444.C7","article-title":"Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels","volume":"108","author":"Demougeot","year":"2003","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121727","article-title":"Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function","volume":"10","author":"Hare","year":"2015","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"Caldwell","year":"2018","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.brainresbull.2009.08.025","article-title":"Vascular dysfunction in retinopathy-an emerging role for arginase","volume":"81","author":"Caldwell","year":"2010","journal-title":"Brain Res. Bull"},{"key":"B7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0022-1759(94)90027-2","article-title":"Determination of arginase activity in macrophages: a micromethod","volume":"174","author":"Corraliza","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"B8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccl.2004.07.001","article-title":"Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes","volume":"22","author":"Deedwania","year":"2004","journal-title":"Cardiol. Clin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1472-8206.2012.01059.x","article-title":"Citrulline: pharmacological perspectives and its role as an emerging biomarker in future","volume":"27","author":"Kaore","year":"2013","journal-title":"Fundam. Clin. Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1210\/jc.2016-2007","article-title":"Arginase inhibition improves microvascular endothelial function in patients with type 2 diabetes mellitus","volume":"101","author":"K\u00f6vamees","year":"2016","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/joim.12461","article-title":"Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels","volume":"279","author":"Pernow","year":"2016","journal-title":"J. Intern. Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mvr.2018.05.010","article-title":"L-Citrulline restores nitric oxide level and cellular uptake at the brain capillary endothelial cell line (TR-BBB cells) with glutamate cytotoxicity","volume":"120","author":"Lee","year":"2018","journal-title":"Microvasc. Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fimmu.2014.00589","article-title":"Arginase in the vascular endothelium: friend or foe?","volume":"5","author":"Lucas","year":"2014","journal-title":"Front. Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10545-005-0467-1","article-title":"Elevated plasma citrulline and arginine due to consumption of Citrullus vulgaris (watermelon)","volume":"28","author":"Mandel","year":"2005","journal-title":"J. Inherit. Metab. Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jphs.2015.02.012","article-title":"L-Citrulline dilates rat retinal arterioles via nitric oxide- and prostaglandin-dependent pathways in vivo","volume":"127","author":"Mori","year":"2015","journal-title":"J. Pharmacol. Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1476-5381.2009.00278.x","article-title":"Recent advances in arginine metabolism: roles and regulation of the arginases","volume":"157","author":"Morris","year":"2009","journal-title":"Br. J. Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1136\/gut.2004.042317","article-title":"Citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection","volume":"53","author":"Osowska","year":"2004","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0014-2999(01)01407-8","article-title":"L-citrulline mediated relaxation in the control and lipopolysaccharide-treated rat aortic rings","volume":"431","author":"Raghavan","year":"2001","journal-title":"Eur. J. Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncpendmet0366","article-title":"Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes","volume":"3","author":"Rask-Madsen","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metabol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chroma.2005.05.009","article-title":"Determination of citrulline in watermelon rind","volume":"1078","author":"Rimando","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1527-3466.2006.00275.x","article-title":"Therapeutic use of citrulline in cardiovascular disease","volume":"24","author":"Romero","year":"2006","journal-title":"Cardiovasc. Drug Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"H159","DOI":"10.1152\/ajpheart.00774.2011","article-title":"Diabetes-induced vascular dysfunction involves arginase I","volume":"302","author":"Romero","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B23","first-page":"4102","article-title":"Plasma arginase activity is elevated in type 2 diabetic patients","volume":"28","author":"Caldwell","year":"2017","journal-title":"Biomedical Research-India"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1152\/ajpendo.1997.272.2.E181","article-title":"Differential regulation of macrophage arginine metabolism: a proposed role in wound healing","volume":"272","author":"Shearer","year":"1997","journal-title":"Am. J. Physiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fimmu.2013.00278","article-title":"Development of novel arginase inhibitors for therapy of endothelial dysfunction","volume":"4","author":"Steppan","year":"2013","journal-title":"Front. Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1073\/pnas.93.13.6770","article-title":"Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury","volume":"93","author":"Xia","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.584669\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T08:53:31Z","timestamp":1608627211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.584669\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":26,"alternative-id":["10.3389\/fphar.2020.584669"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.584669","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,22]]},"article-number":"584669"}}